GI Discovery Platform
Measures metabolomic signatures of the gut mucosal-immune system to enable therapeutic discovery, development, and clinical decision support.
3 Leading Use Cases
CS Therapeutic Platform
Mucosal Immune Modulator (MIM) therapeutic that restores and protects the mucosal-immune barrier in the gastrointestinal tract.
7 Indications
Lead Asset: CS-0003
Our focus is on preventing and treating GI disease with novel therapeutics & GI Discovery platform.
– Physicians’ Hippocratic Oath
